Yanhong Li

Title: Yanhong Li: Innovator in E-Selectin Antagonist Research

Introduction

Yanhong Li is a prominent inventor based in Rockville, MD (US), known for her significant contributions to the field of biomedical research. With a total of six patents to her name, she has made remarkable strides in developing methods and compositions for treating various diseases.

Latest Patents

Her latest patents focus on E-selectin antagonist compounds, compositions, and methods of use. These innovations provide methods and compositions for the treatment and prevention of diseases and disorders that can be addressed by inhibiting the binding of E-selectin to its ligand. The patents describe E-selectin antagonists, including glycomimetic compounds, antibodies, aptamers, and peptides. These compounds are particularly useful in treating cancers, preventing metastasis, inhibiting the infiltration of cancer cells into bone marrow, and reducing adhesion of cancer cells to endothelial cells, including those in bone marrow. Additionally, they play a role in inhibiting thrombus formation.

Career Highlights

Yanhong Li is currently associated with Glycomimetics, Inc., where she continues her groundbreaking research. Her work has been instrumental in advancing therapeutic strategies that target E-selectin, showcasing her expertise and dedication to improving patient outcomes.

Collaborations

Some of her notable coworkers include John L Magnani and Arun K Sarkar, who have collaborated with her on various projects related to E-selectin antagonists.

Conclusion

Yanhong Li's innovative research and patents in the field of E-selectin antagonists highlight her as a leading figure in biomedical innovation. Her contributions are paving the way for new treatments that could significantly impact cancer therapy and patient care.